LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

London, UK (January 14, 2022): LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its SARS-CoV-2 Antigen test detects the Omicron Variant. In-house wet testing with live Omicron virus demonstrated that the LumiraDx SARS-CoV-2 Antigen test detects...

Translate »
topbar-lumiradx-popup

Estás apunto de ser redirigido a:
www.lumiradx.com/uk-en/